在评估研究活检的伦理性时,正确定义和报告二次终点是至关重要的
Laura A Levit1, Elizabeth Garrett-Mayer1, Jeffrey Peppercorn2
1Center for Research and Analytics, American Society of Clinical Oncology, Alexandria, VA, USA.
Clinical trials (London, England)
|April 24, 2024
概括
在癌症临床试验中实施研究活检的伦理框架面临着挑战. 关键问题包括定义次要终点,克服科学/监管障碍,并为患者的利益激励活检.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 生物伦理学生物伦理学
背景情况:
- 美国临床瘤学会为癌症临床试验中的研究活检制定了伦理框架.
- 实施这一框架在瘤学研究界提出了实际和道德上的挑战.
研究的目的:
- 审查瘤学临床试验中研究活检的伦理框架的实施挑战.
- 确定需要注意的关键领域,以成功整合研究活检.
主要方法:
- 美国临床瘤学会伦理框架的审查.
- 分析与定义,科学/监管方面以及激励措施相关的实施挑战.
- 讨论研究管理原则和参与者保护.
主要成果:
- 确定了主要的实施挑战:二次终点的定义,科学和监管框架以及激励结构.
- 对于强制性研究活检,需要明确阐述科学目标.
- 证明二次终点和保护参与者利益的重要性.
结论:
- 成功实施需要解决终点定义,监管清晰度和适当的激励措施.
- 坚持研究管理对于伦理行为和患者对瘤学临床试验的信任至关重要.
- 对clinicaltrials.gov和文献的准确报告对于透明度和科学进步至关重要.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Ethics and Bioethics
1.4K
Ethics is a philosophical study of moral actions. Ethics attempts to determine what is valuable for individuals and society. It examines the rational justification of moral judgments and analyzes what is morally just, fair, and right. Bioethics is a sub-discipline of applied ethics that analyzes the philosophical, social, and legal issues in life sciences and medicine. Ethical theories serve as a foundation for decision-making and represent the viewpoints from which people seek direction. They...
1.4K
Kaplan-Meier Approach
133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133


